Company news
CytomX Therapeutics, Inc. news in 2021
CytomX Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
CytomX Therapeutics Announces Preliminary Results for Ongoing Phase 2 Expansion Study of CX-2029, a First-in-Class Antibody-Drug Conjugate Candidate Targeting the Transferrin Receptor, CD71
December 19, 2021
CytomX Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
November 3, 2021
CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Cytokine Platform at Society for Immunotherapy of Cancer Annual Meeting
October 31, 2021
CytomX Therapeutics to Announce Third Quarter 2021 Financial Results on November 4, 2021
October 27, 2021
CytomX Therapeutics Appoints Dr. Alan Ashworth to Board of Directors
October 3, 2021
CytomX Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 6, 2021
CytomX Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update
August 4, 2021
CytomX Therapeutics Announces Multiple Publications on Pacmilimab (CX-072), a Conditionally Activated Inhibitor of Programmed Death-Ligand 1 (PD-L1)
August 3, 2021
CytomX Therapeutics to Present at Upcoming August Investor Conferences
August 1, 2021
CytomX Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021
July 28, 2021
CytomX Therapeutics Announces Publication of First-in-Human Data for CX-2029 in Clinical Cancer Research
June 20, 2021
CytomX Therapeutics to Present at Jefferies Virtual Healthcare Conference
May 26, 2021
CytomX Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update
May 5, 2021
CytomX Therapeutics to Announce First Quarter 2021 Financial Results on May 6, 2021
April 28, 2021
CytomX Therapeutics to Host Virtual Investor Event on April 7, 2021
March 23, 2021
CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
February 23, 2021
CytomX Therapeutics to Present at Upcoming March Virtual Investor Conferences
February 21, 2021
CytomX Therapeutics Announces New Employment Inducement Grant
February 18, 2021
CytomX Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
February 16, 2021
CytomX Therapeutics to Present at Guggenheim Healthcare Talks 2021 Oncology Day
February 3, 2021
CytomX Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 2, 2021
CytomX Therapeutics Announces Closing of Public Offering of Common Stock
January 25, 2021
CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock
January 19, 2021
CytomX Therapeutics Announces Proposed Public Offering of Common Stock
January 18, 2021
CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 6, 2021
Calls in 2021
- CytomX Therapeutics (NASDAQ:CTMX) Q3 2021 Earnings Call
Nov 4, 2021
Transcript - CytomX Therapeutics (NASDAQ:CTMX) Q2 2021 Earnings Call
Aug 5, 2021
Transcript - CytomX Therapeutics (NASDAQ:CTMX) Q1 2021 Earnings Call
May 6, 2021
Transcript - CytomX Therapeutics (NASDAQ:CTMX) Q4 2020 Earnings Call
Feb 24, 2021
Transcript